Conversely, a study performed on a different p66Shc-/- mouse model, named ShcL, demonstrated that reduced p66Shc levels improved insulin sensitivity in adipocytes, muscles, and the liver without preventing diet-induced obesity [47]. Here, INS is linked to obesity disorder.